The global animal vaccines market size was US$ 8.5 billion in 2021. The global animal vaccines market is forecast to grow to US$ 13.3 billion by 2030 by growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2022 to 2030.

Factors Influencing the Market

Veterinary vaccines play an essential role in keeping both animals and the public safe. Moreover, the growing adoption of pets like dogs and cats and ever-increasing animal population will fuel the growth of the animal vaccine market during the study period.

Rising awareness about the preventive measures to prevent zoonotic diseases will drive market growth. Furthermore, the growing prevalence of diseases such as human rabies, infectious diseases like canine distemper in dogs, foot and mouth disease (FMD), and contagious bovine pleuropneumonia (CBPP) will escalate the demand for animal vaccines in the coming years.

Developments in the medical industry have significantly surged the advancements in recombinant modified live chimeric vaccines, gene-deleted marker vaccines, DNA vaccines, virus-like-particle vaccines, virus vaccines, etc. Thus, it will benefit the global animal vaccines market during the forecast period.

The adverse impact of animal vaccines on the health of humans and animals may limit their demand during the study period.

Regional Analysis

The Asia-Pacific animal vaccine market is forecast to emerge as the largest market in terms of revenue. It is owing to the growing population in the region. In addition to that, the rising production of vaccines to cater to the healthcare needs of pets is expected to boost the demand for animal vaccines during the forecast period. The availability of cost-effective veterinary vaccinations will also benefit the market in the region. Apart from that, raising awareness about the need for the protection of livestock from mass wipe-outs will upsurge the demand for animal vaccines during the study period.

COVID-19 Impact Analysis

The wake of the COVID-19 pandemic negatively affected the animal vaccines companies. The pandemic has significantly impacted the animal vaccines industry due to the shift in consumer preference. Healthcare bodies started focusing on COVID-19 affected patients, which reduced the production and demand for animal vaccines. In addition to that, lockdowns and changing animal healthcare approach further hampered the growth of the market. The global animal vaccines market also witnessed a tremendous fall due to the unavailability of the workforce and raw materials.

Competitors in the Market

Merck & Co., Inc.
Vaxxinova
Ceva Sant Animale
Sanofi S.A.
Romvac
Zoetis Inc.
Boehringer Ingelheim GmbH
Biovac
Merial
Anicon Labor GmbH
Nexvet
PHL Associates, Inc.
Hygieia Biological Laboratories
Colorado Serum Company
Pfizer
Arko Laboratories, Ltd.
Other Prominent Players
Market Segmentation

The global animal vaccine market segmentation focuses on Product, Animal Type, and Region.

By Product Outlook

Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines
By Animal Type Outlook

Companion animal
Dogs
Cats
Livestock animal
Cattle
Pigs
Poultry
Sheep
Others
Aquaculture
By Regional Outlook

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America